retatrutide phase 2 trial type 2 diabetes weight loss 2024 TRIUMPH-4 Results: Are We Witnessing a New Era in Obesity Management? Retatrutide produces up to 30.3%

Feel your best with a plan built just for you Ingredient Name 1 Ingredient Body 1 Ingredient Name 1 Ingredient Body 1 Ingredient Name 2 Ingredient Body 2 Ingredient Name 1 Ingredient Body 1 Ingredient Name 2 Ingredient Body 2 Ingredient Name 3 Ingredient Body 3 Ingredient Name 1 Ingredient Body 1 Ingredient Name 2 Ingredient Body 2 Ingredient Name 3 Ingredient Body 3 Ingredient Name 4 Ingredient Body 4 Backed by our doctors & specialist teams Holistic care We support your journey with expert guidance and resources to help you achieve optimal results, including fitness programs, dietitian-designed meal plans, and practical lifestyle tips

In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise

Known and Potential Long-Term Side Effects of Retatrutide How Long-Term Risks Are Monitored in Clinical Trials Managing Side Effects: Guidance Based on Current Evidence Who May Be at Greater Risk of Adverse Effects Over Time What to Discuss With Your Doctor Before Starting Retatrutide Scientific References Frequently Asked Questions What Is Retatrutide and How Does It Work

Plans are designed to integrate smoothly into your daily routine